Evidence mapPaperPMID 29650631Full record

ReviewCirculation research2018

The Vasculature in Prediabetes.

David H Wasserman, Thomas J Wang, Nancy J Brown

Registry-linked trialOpen access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07079722 (Educational Program for Type 2 Diabetes Prevention With Integrated Physical Exercise), which is not on this map. Cited by 66 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07079722 narecruitingnot on this mapstarted 2025, after this paper: background citation

Educational Program for Type 2 Diabetes Prevention With Integrated Physical Exercise: Digital and In-Person Approach

TypeinterventionalSponsorFaculdade de Motricidade HumanaRan2025 to 2026Enrolled90ConditionsPre-diabetesArmsExercise
3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 1 synthesis or guideline pooled it, 136 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Increased cGMP improves microvascular exercise training adaptations in diet-induced obesity.American journal of physiology. Endocrinology and metabolism · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Insulin resistance, CaFrontiers in physiology · 2025
    Review
  16. Article
  17. The Association between Functional Dyspepsia and Metabolic Syndrome-The State of the Art.International journal of environmental research and public health · 2024
    Review
  18. Review
  19. Review
  20. The Emerging Role of Prediabetes and Its Management: Focus on L-Arginine and a Survey in Clinical Practice.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2023
    Review

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

David H WassermanFrom the Departments of Molecular Physiology and Biophysics (D.H.W.) and Medicine (T.J.W., N.J.B.), Vanderbilt University Medical Center, Nashville, TN.
Thomas J WangFrom the Departments of Molecular Physiology and Biophysics (D.H.W.) and Medicine (T.J.W., N.J.B.), Vanderbilt University Medical Center, Nashville, TN.
Nancy J BrownFrom the Departments of Molecular Physiology and Biophysics (D.H.W.) and Medicine (T.J.W., N.J.B.), Vanderbilt University Medical Center, Nashville, TN. Nancy.j.brown@vanderbilt.edu.
Vanderbilt University Medical Center · US

Funding

Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · VANDERBILT UNIVERSITY · 2001 to 2005
$5.3M
EXERCISE AND FUEL METABOLISMR01DK050277 · VANDERBILT UNIVERSITY · 1995 to 2005
$2.1M
PHARMACOLOGY AND PHYSIOLOGY OF CARDIOVASCULAR DISEASEST32HL007411 · VANDERBILT UNIVERSITY · 1985 to 2005
$1.7M
INTEGRATED CONTROL OF MUSCLE GLUCOSE UPTAKE IN VIVOR01DK054902 · VANDERBILT UNIVERSITY · 1999 to 2005
$1.5M
Metabolomic predictors of insulin resistance and diabetesR01DK081572 · BETH ISRAEL DEACONESS MEDICAL CENTER · 2025 to 2025
$649k
NHLBI NIH HHS R01 HL102780NHLBI NIH HHS R01 HL125426NHLBI NIH HHS R01 HL128983NHLBI NIH HHS R01 HL132320NHLBI NIH HHS T32 HL007411NIDDK NIH HHS R01 DK050277NIDDK NIH HHS R01 DK054902NIDDK NIH HHS R01 DK081572NIDDK NIH HHS R01 DK108159NIDDK NIH HHS R24 DK096527NIDDK NIH HHS R37 DK050277NIDDK NIH HHS R56 DK054902NIDDK NIH HHS U24 DK059637NIDDK NIH HHS U2C DK059637
6 · The paper itself

Abstract

The frequency of prediabetes is increasing as the prevalence of obesity rises worldwide. In prediabetes, hyperglycemia, insulin resistance, and inflammation and metabolic derangements associated with concomitant obesity cause endothelial vasodilator and fibrinolytic dysfunction, leading to increased risk of cardiovascular and renal disease. Importantly, the microvasculature affects insulin sensitivity by affecting the delivery of insulin and glucose to skeletal muscle; thus, endothelial dysfunction and extracellular matrix remodeling promote the progression from prediabetes to diabetes mellitus. Weight loss is the mainstay of treatment in prediabetes, but therapies that improved endothelial function and vasodilation may not only prevent cardiovascular disease but also slow progression to diabetes mellitus.

Indexed as

MicrocirculationAngiotensin-Converting Enzyme InhibitorsAnimalsBlood VesselsCardiovascular DiseasesCombined Modality TherapyDiabetes Mellitus, Type 2Diet, ReducingDisease ProgressionEndothelium, VascularExtracellular MatrixFatty Acids, NonesterifiedFibrinolysisGlucoseHumansHyperglycemiaAngiotensin-Converting Enzyme InhibitorsFatty Acids, NonesterifiedGlucoseHypoglycemic AgentsMicroRNAscardiovascular diseaseextracellular matrixinsulin resistancemetabolic syndromeobesity

Identifiers

PMID29650631
PMCPMC5901903
OpenAlexW2797223469

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.